Roger Cady

Eptinezumab initiated during a migraine prolongs time to subsequent attacks 4:37
Eptinezumab initiated during a migraine prolongs time to subsequent attacks
Roger Cady • 15 Jun 2021
Patient-identified most bothersome symptom as a novel outcome measure in migraine prevention trials 2:41
Patient-identified most bothersome symptom as a novel outcome measure in migraine prevention trials
Roger Cady • 15 Jun 2021
How does eptinezumab differ from other migraine treatments? 2:27
How does eptinezumab differ from other migraine treatments?
Roger Cady • 15 Jun 2021
RELIEF trial results: eptinezumab demonstrates efficacy when administered during a migraine attack 4:47
RELIEF trial results: eptinezumab demonstrates efficacy when administered during a migraine attack
Roger Cady • 15 Jun 2021
The content of VJNeurology is intended for healthcare professionals